Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Subcutaneous intersectional short-pulse brain stimulation for epilepsy

Official title: Changes in Brain Activity as a Function of Scalp and Subcutaneous Electrical Stimulation Parameters in Epileptic Patients

Run by Semmelweis University · NCT07041619 · Data updated 2026-11-12

This trial tries a new subcutaneous intersectional short-pulse (ISP) electrical stimulation system to see if it can safely reduce seizure frequency and severity in adults with drug-resistant epilepsy who are not candidates for surgery.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment30 (estimated)
SponsorSemmelweis University
Academic / other
Locations1 site (Budapest)
StatusRecruiting
StartedNovember 15, 2021
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJuly 3, 2025
Trial IDNCT07041619 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 with drug-resistant focal epilepsy who are not suitable for resective surgery, experience four or more focal seizures per month (or frequent EEG spike activity), and can manage wound care at home are ideal candidates.

Probably not a fit

Patients who are suitable for resective surgery, have progressive brain lesions or serious comorbidities or coagulopathy, are under 18, or have contraindicated implanted electrical devices or autoimmune etiologies are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study implants MRI-guided, subcutaneous electrodes beneath the scalp and uses ultra-brief, distributed ISP pulses to concentrate electric fields on targeted brain areas while limiting effects on surrounding tissue. After implantation, patients undergo continuous EEG to capture baseline seizures and to test tolerable stimulation parameters. An automated seizure-detection algorithm (with close clinical supervision) triggers ISP at seizure onset to try to prevent progression, while safety and tolerability are continuously monitored. Electrodes are removed after data collection and patients receive follow-up assessments to document any lasting effects or adverse events.

Why it matters

Potential benefit: If successful, ISP could lower seizure frequency and severity and offer a less-invasive neuromodulation option for patients who cannot have resective surgery.

How similar studies have gone: Responsive neurostimulation and deep brain stimulation have reduced seizures in some patients, but ISP is a novel ultra-brief, subcutaneous approach with only early preclinical efficacy data so far.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18-65 years
* Patients with drug-resistant focal epilepsy who, after non-invasive or invasive EEG monitoring and neuropsychological, epilepsy protocol cranial MRI, or FDG-PET/CT or FDG-PET/MRI and/or ictal SPECT, have been declared unfit for resective epilepsy surgery by an interdisciplinary epilepsy team.
* Diagnosis of focal or idiopathic generalised epilepsy
* With antiepileptic drugs, 4 or more focal seizures per month, or frequent spike-wave activity on EEG - min 10 sec/hour.
* A patient who is fit to care for the wound and whose home environment this in terms of compliance and cleanliness

Exclusion Criteria:

* subjects under 18 years old
* If the patient is suitable for resective surgery or if there are questions about the patient's suitability for resective surgery of autoimmune aetiology
* Progressive brain lesions on MRI or a serious internal organ disease or coagulopathy considered serious by your doctor
* Subjects who have an electrical energy transmitting implant implanted in the brain or other organ(s), including pacemakers, intracardiac defibrillators and any device meeting this definition
* Pregnancy. Pregnancy should be checked by a pregnancy test for all women of childbearing potential
* Previous traumatic brain and skull injury, stroke are not exclusionary, but in all such cases the examining physician and the Neunos technical support team should be consulted
* The presence of metal implants is generally considered contraindicated. In all such cases, the investigating physician or the Neunos technical support team should be consulted

Where it's running

  • Semmelweis University Neurosurgery and Neurointerventional Clinic
    Budapest, Hungary
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.